The Weinberg Group solves critical business problems leveraging the talent of an elite team of scientists. As a multinational scientific and regulatory consulting firm, we help companies resolve complex issues surrounding science, management, law and regulation. Since 1983, we have been committed to helping our clients address regulatory requirements, improve manufacturing processes and support products in the legal system, the media and in the court of public opinion.
Specialties
Pharmaceuticals, Biologics, Biotech, Medical Devices, Diagnostics, IVDs, GCP Compliance, Clinical Pharmacology, Consulting, GLP Compliance, GMP Compliance, Quality Assurance/Control, Regulatory Affairs/Regulatory Strategy, Regulatory Document Preparation
The Weinberg Group Company Blog
The Weinberg Group Activity on LinkedIn
-
The Weinberg Group Filing an NDA? Read the latest Weinberg on FDA post for what to expect during the review process http://www.weinbergonfda.com/index.php/2012/02/what-to-expect-during-nda-review/ -
-
The Weinberg Group New Weinberg on FDA Post: What is the Difference Between Required and Nice to Know in Drug Development?
-
The Weinberg Group Thanks to all who attended our webinar today!
-
The Weinberg Group Have you registered for today's webinar? Theres still time! Visit the link below to make sure you do not miss out on Dr. Bob Roth's presentation "Understanding What FDA is Looking for in Postmarket Safety Assessments: Going Beyond AERS"
-
The Weinberg Group Don't forget to register for tomorrow's Postmarket Safety Assessments webinar: https://event.on24.com/eventRegistration/EventLobbyServlet?target=registration.jsp&eventid=396991&sessionid=1&key=0CF19E5E42EBF48B5E1A75814867CFD0&sourcepage=register
-
The Weinberg Group New Weinberg on FDA Blog Post- Update on Postmarket Study Commitments: It's Not What You Count, But How You Count It
-
-
The Weinberg Group Our Postmarket Safety Assessments webinar is one week from tomorrow! Sign up here bit.ly/wEygHP
-
The Weinberg Group New Blog Post: Citing the IIG as Evidence of Ingredient Safety Comes with Caveats
